What are the Challenges in Developing Nanotechnology-based Anti-inflammatory Agents?
Despite their potential, the development of nanotechnology-based anti-inflammatory agents faces several challenges: - Safety and Toxicity: The long-term safety and potential toxicity of nanoparticles remain a concern. Rigorous testing and regulatory approval are required to ensure their safe use. - Manufacturing and Scalability: The production of nanoparticles requires sophisticated techniques and equipment, which can be expensive and difficult to scale up. - Regulatory Hurdles: The regulatory pathways for nanomedicines are still evolving, and obtaining approval can be complex and time-consuming. - Stability and Storage: Ensuring the stability of nanoparticles during storage and use is crucial for maintaining their efficacy.
